MedTrace Logo

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

NCT03035474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5749

Last updated 2021-01-25

No results posted yet for this study

Summary

CONNECT-HF is a large-scale, pragmatic, cluster-randomized clinical trial to evaluate the effect of a customized, multifaceted, health system-level quality-improvement (QI) program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics.

Conditions

Interventions

OTHER

Digital Engagement

Patient engagement to improve self-management/medication adherence

OTHER

Direct Engagement

Health system engagement to improve local QI programs

Sponsors & Collaborators

  • Duke Clinical Research Institute

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Adam DeVore, MD, MHS · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-21
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03035474 on ClinicalTrials.gov